While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the antibody response in saliva and its relationship to systemic …

Although SARS-CoV-2 infects the upper respiratory tract, we know little about the amount,
type, and kinetics of antibodies (Ab) generated in the oral cavity in response to COVID-19 …

Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-mutation-driven
clonal evolution and subsequent transformation is a crucial step toward the design …

We enrolled 91 consecutive inpatients with COVID-19 at 6 hospitals in Toronto, Canada,
and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT-…

Objectives Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has been instrumental in detecting previous exposures and analyzing vaccine‐…

Prioritizing Ontario’s long-term care home (LTCH) residents for vaccination against severe
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …

While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the mucosal immune response and its relationship to systemic …

Background We determined the burden of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in air and on surfaces in rooms of patients hospitalized with coronavirus …

… Salomon-Shulman; Grace Blacker; Mahya Fazel-Zarandi; Bhavisha Rathod; Karen Colwell;
Alainna Jamal; Zhijie Li; Keelia Quinn de Launay; Alyson Takaoka; Christine Fahim; Aimee …

TP53 is the most commonly mutated gene in human cancer, typically occurring in association
with complex cytogenetics and dismal outcomes. Understanding the genetic and non-…